MicroPort

MicroPort® originated from Shanghai MicroPort Medical (Group) Co., Ltd., which was founded in 1998. It is an innovative high-end medical device group headquartered in Zhangjiang Science City, Shanghai, China. Major production (R&D) bases have been established in Shanghai, Suzhou, Jiaxing, and Shenzhen in China; Memphis in the United States; near Paris in France; near Milan in Italy; and in the Dominican Republic, forming a global R&D, production, marketing, and service network. MicroPort® is committed to providing universally accessible, high-quality solutions that extend and reshape life. MicroPort® has over 300 marketed products covering twelve major business clusters: cardiovascular and structural heart disease, electrophysiology and cardiac rhythm management systems, bone and soft tissue repair technology, aortic and peripheral vascular diseases, cerebrovascular and neuromodulation sciences, surgical emergencies and robotics, endocrine management and assisted reproduction, urology, gynecology, digestive, respiratory diseases, ear, nose, mouth, eye, and body contouring aesthetics, in-vitro diagnostics and internal/external imaging, intra-body solid tumor treatment technology, insomnia, depression, and rehabilitation medicine. MicroPort® products have entered more than ten thousand hospitals worldwide. Globally, on average, a MicroPort® product is used every six seconds to save lives, improve quality of life, or assist in creating new life.